Wellington Management Group’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,954,413
| Closed | -$57.9M | – | 2003 |
|
|
2023
Q4 | $57.9M | Sell |
1,954,413
-11,304,584
| -85% | -$225M | 0.01% | 672 |
|
|
2023
Q3 | $210M | Buy |
13,258,997
+3,506,098
| +36% | +$58.3M | 0.04% | 358 |
|
|
2023
Q2 | $184M | Sell |
9,752,899
-111,886
| -1% | -$1.32M | 0.03% | 408 |
|
|
2023
Q1 | $37.9M | Buy |
9,864,785
+638,077
| +7% | +$2.72M | 0.01% | 759 |
|
|
2022
Q4 | $45.8M | Sell |
9,226,708
-780,797
| -8% | -$4.23M | 0.01% | 711 |
|
|
2022
Q3 | $47.8M | Sell |
10,007,505
-709,580
| -7% | -$3.74M | 0.01% | 682 |
|
|
2022
Q2 | $48.2M | Sell |
10,717,085
-2,346,399
| -18% | -$10.2M | 0.01% | 688 |
|
|
2022
Q1 | $62.2M | Sell |
13,063,484
-839,014
| -6% | -$4.65M | 0.01% | 687 |
|
|
2021
Q4 | $103M | Sell |
13,902,498
-165,610
| -1% | -$1.03M | 0.02% | 622 |
|
|
2021
Q3 | $79.8M | Sell |
14,068,108
-524,462
| -4% | -$3.03M | 0.01% | 686 |
|
|
2021
Q2 | $96.2M | Sell |
14,592,570
-4,410,910
| -23% | -$30.8M | 0.02% | 644 |
|
|
2021
Q1 | $154M | Sell |
19,003,480
-3,080,623
| -14% | -$25.2M | 0.03% | 486 |
|
|
2020
Q4 | $142M | Sell |
22,084,103
-996,025
| -4% | -$5.81M | 0.03% | 495 |
|
|
2020
Q3 | $83.1M | Sell |
23,080,128
-231,510
| -1% | -$935K | 0.02% | 568 |
|
|
2020
Q2 | $107M | Buy |
23,311,638
+4,160,256
| +22% | +$17.7M | 0.02% | 502 |
|
|
2020
Q1 | $65.3M | Buy |
19,151,382
+19,109,675
| +45,819% | +$83.5M | 0.02% | 558 |
|
|
2019
Q4 | $213K | Buy |
+41,707
| New | +$142K | ﹤0.01% | 1980 |
|
|
2019
Q3 | – | Sell |
-194,701
| Closed | -$423K | – | 2142 |
|
|
2019
Q2 | $423K | Buy |
194,701
+152,991
| +367% | +$362K | ﹤0.01% | 1930 |
|
|
2019
Q1 | $113K | Buy |
+41,710
| New | +$181K | ﹤0.01% | 2016 |
|
|
2018
Q4 | – | Sell |
-19,495
| Closed | -$185K | – | 2236 |
|
|
2018
Q3 | $185K | Sell |
19,495
-228,001
| -92% | -$2.19M | ﹤0.01% | 2185 |
|
|
2018
Q2 | $2.41M | Buy |
247,496
+44,758
| +22% | +$472K | ﹤0.01% | 1677 |
|
|
2018
Q1 | $2.13M | Sell |
202,738
-203,923
| -50% | -$2.01M | ﹤0.01% | 1712 |
|
|
2017
Q4 | $2.61M | Buy |
406,661
+94,898
| +30% | +$585K | ﹤0.01% | 1647 |
|
|
2017
Q3 | $2.38M | Buy |
+311,763
| New | +$2.07M | ﹤0.01% | 1677 |
|
|
2016
Q4 | – | Sell |
-182,591
| Closed | -$489K | – | 2289 |
|
|
2016
Q3 | $489K | Sell |
182,591
-111,308
| -38% | -$324K | ﹤0.01% | 1986 |
|
|
2016
Q2 | $905K | Buy |
293,899
+14,186
| +5% | +$88.9K | ﹤0.01% | 1800 |
|
|
2016
Q1 | $2.38M | Buy |
279,713
+60,327
| +27% | +$510K | ﹤0.01% | 1557 |
|
|
2015
Q4 | $2.98M | Buy |
+219,386
| New | +$2.7M | ﹤0.01% | 1514 |
|
|
2014
Q4 | – | Sell |
-633,248
| Closed | -$6.71M | – | 2259 |
|
|
2014
Q3 | $6.71M | Sell |
633,248
-674,252
| -52% | -$7.63M | ﹤0.01% | 1356 |
|
|
2014
Q2 | $15.5M | Sell |
1,307,500
-1,819,051
| -58% | -$22.8M | ﹤0.01% | 1123 |
|
|
2014
Q1 | $46.7M | Sell |
3,126,551
-54,146
| -2% | -$854K | 0.01% | 763 |
|
|
2013
Q4 | $46.7M | Sell |
3,180,697
-176,820
| -5% | -$2.72M | 0.01% | 763 |
|
|
2013
Q3 | $57.1M | Sell |
3,357,517
-170,675
| -5% | -$3M | 0.02% | 667 |
|
|
2013
Q2 | $58.5M | Buy |
+3,528,192
| New | +$57.2M | 0.02% | 638 |
|
Other funds holding IMGN
Wellington Management Group's IMGN Position: Q1 2024 in Review
Wellington Management Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,954,413 shares — an estimated $57.9M sold.
Wellington Management Group first reported a position in IMGN in Q2 2013 and held it in 34 quarters. The position peaked at $210M in Q3 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Wellington Management Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Wellington Management Group sold 1,954,413 Immunogen Inc shares in Q1 2024, an estimated $57.9M.
- Wellington Management Group first reported a position in Immunogen Inc in Q2 2013 and held it in 34 quarters.
- Wellington Management Group's Immunogen Inc position peaked at $210M in Q3 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Wellington Management Group's 13F filing for Q1 2024, filed 15 May 2024.